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CDKL5 kinase controls transcription-coupled
responses to DNA damage
Taran Khanam1, Ivan Mu~noz1 , Florian Weiland1,† , Thomas Carroll1, Michael Morgan1,‡,
Barbara N Borsos2, Vasiliki Pantazi2, Meghan Slean1,§, Miroslav Novak1,–, Rachel Toth3, Paul Appleton4,
Tibor Pankotai2, Houjiang Zhou1,†† & John Rouse1,*
Abstract
Mutations in the gene encoding the CDKL5 kinase are among
the most common genetic causes of childhood epilepsy and can
also give rise to the severe neurodevelopmental condition CDD
(CDKL5 deficiency disorder). Despite its importance for human
health, the phosphorylation targets and cellular roles of CDKL5
are poorly understood, especially in the cell nucleus. Here, we
report that CDKL5 is recruited to sites of DNA damage in
actively transcribed regions of the nucleus. A quantitative phos-
phoproteomic screen for nuclear CDKL5 substrates reveals a
network of transcriptional regulators including Elongin A (ELOA),
phosphorylated on a specific CDKL5 consensus motif. Recruit-
ment of CDKL5 and ELOA to damaged DNA, and subsequent
phosphorylation of ELOA, requires both active transcription and
the synthesis of poly(ADP-ribose) (PAR), to which CDKL5 can bind.
Critically, CDKL5 kinase activity is essential for the transcrip-
tional silencing of genes induced by DNA double-strand breaks.
Thus, CDKL5 is a DNA damage-sensing, PAR-controlled transcrip-
tional modulator, a finding with implications for understanding
the molecular basis of CDKL5-related diseases.
Keywords CDKL5 disorder; DNA damage response; kinase; poly(ADP-ribose);
transcriptional regulation
Subject Categories DNA Replication, Recombination & Repair; Post-transla-
tional Modifications & Proteolysis; Proteomics
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Introduction
Cyclin-dependent kinase-like 5 (CDKL5) is a poorly characterized
protein kinase, which is mutated in a rare, debilitating condition
known as CDKL5 deficiency disorder (CDD; OMIM 300203; 300672)
(Kalscheuer et al, 2003; Fehr et al, 2013). In particular, CDD is char-
acterized by seizure onset usually before 3 months of age, severe
neurodevelopmental delays, grievously impaired motor, language
and hand skills, cortical visual impairment and other symptoms
(Fehr et al, 2013). Current treatments for CDD focus on the manage-
ment of symptoms, not the underlying cause of the disease.
Although CDD is rare, it was recently discovered that CDKL5 is one
of the most commonly mutated genes in childhood epilepsy, and
CDKL5 mutations have also been associated with milder syndromes
typified by intellectual disability and behavioural defects (Krishnaraj
et al, 2017; MacKay et al, 2020). Thus, the prevalence of CDKL5
mutations is much higher than thought previously. Developing
rational therapies to treat the root cause of CDKL5-related diseases
requires an understanding of the molecular basis of these diseases
and the basic functions of CDKL5. However, at present the phospho-
targets and cellular roles of this kinase are poorly understood. Iden-
tifying the cellular targets of CDKL5 is crucial because the CDD-
associated mutations strongly reduce kinase activity (Munoz et al,
2018), suggesting that the reduced phosphorylation of CDKL5 target
proteins causes brain dysfunction and disease.
Recently, we and others described complementary substrate
screens to identify physiological targets of CDKL5 (Baltussen et al,
2018; Eyers, 2018; Munoz et al, 2018). These efforts revealed a
network of microtubule and centrosome regulators phosphorylated
by CDKL5, including MAP1S, CEP131, ARHGEF2, EB2 and DLG5.
The phosphorylated serine in all of these targets lies in a common
motif: R-P-X-S-A. Experiments with synthetic peptides correspond-
ing to the sequence around the CDKL5 phosphorylation site Ser900
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in MAP1S provided information on CDKL5 specificity. Whereas
substitution of the R and P residues upstream of the phospho-
acceptor S abolishes phosphorylation by CDKL5, a G or P residue at
the +1 position could be accommodated instead of the A; further-
more, T can be accommodated as the phospho-acceptor residue
(Munoz et al, 2018). These data suggested that the motif R-P-X-[S/
T]-[A/G/P] represents a putative CDKL5 consensus motif.
The microtubule-associated substrates of CDKL5 are based in the
cytoplasm. However, CDKL5 is also located in the nucleus but little
is known about its functions in this compartment, and nuclear phos-
photargets were conspicuously absent from the published screens
(Baltussen et al, 2018; Munoz et al, 2018). A recent report found
that CDKL5 promotes renal injury in mice exposed to toxic insults
by upregulating SOX9-dependent genes (Kim et al, 2020). This role
was linked to phosphorylation of SOX9, but the phosphoserine
reported to be phosphorylated by CDKL5 (Q-T-H-I-phospho-S199-P)
does not lie in an R-P-X-[S/T]-[A/G/P] motif and is therefore unli-
kely to be a direct CDKL5 target. Thus, there is an urgent need to
identify CDKL5 targets in the nucleus to help understand its roles in
this cellular compartment.
Protein kinases in the nucleus play vitally important roles in the
sensing, signalling and repair of DNA damage, in particular the
related kinases ATM, DNA-PK and ATR (Jette & Lees-Miller, 2015;
Blackford & Jackson, 2017). These kinases transduce DNA damage
signals, triggering a pleiotropic series of protective reactions collec-
tively known as the DNA damage response (DDR), which prevents
genome instability (Marechal & Zou, 2013; Shiloh & Ziv, 2013;
Blackford & Jackson, 2017). Mutations in these kinases cause severe
DNA repair defects and diseases typified by rampant genome insta-
bility including ataxia telangiectasia (ATM) and Seckel syndrome
(ATR) (Blackford & Jackson, 2017). Although other kinases have
been implicated in the DDR such as CHK1, CHK2, p38, JNK, MK2
and others (Smith et al, 2020), the overall proportion of the 560+
kinases in the human kinome (and the dark kinome (Berginski et al,
2021)) implicated in the DDR is low, and we speculated there may
be more, perhaps with relevance to human diseases.
With the aim of expanding the repertoire of DDR kinases, we
started screening the human kinome for kinases that are recruited to
DNA damage sites. Here, we demonstrate that CDKL5 is recruited to
DNA breaks in actively transcribed regions of the nucleus in a
manner that requires the synthesis of poly(ADP-ribose) (PAR), to
which CDKL5 can bind. We present the results of a screen to iden-
tify nuclear targets of CDKL5, including Elongin A (ELOA) whose
recruitment and phosphorylation at Ser311 require PAR synthesis
and transcriptional activity like CDKL5. CDD-associated CDKL5
mutations severely reduced ELOA phosphorylation by CDKL5.
Finally, we show that CDKL5 is required for silencing of transcrip-
tion known to occur near DNA breaks.
Results
CDKL5 is recruited to damaged chromatin in a poly(ADP-ribose)-
dependent manner
Recruitment to DNA damage sites appears to be a universal feature
of proteins regulating the vast range of protective responses encom-
passed by the cellular DDR (Aleksandrov et al, 2018). With the aim
of expanding the repertoire of DDR kinases, we started screening
the human kinome for kinases recruited to DNA damage sites. U–2–
OS cells were stably transfected with an mCherry-tagged form of the
DNA repair nuclease FAN1 to mark DNA damage sites. These cells
were transiently transfected with GFP-tagged kinases individually,
starting with the CMGC branch of the human kinome (Fig EV1A).
After pre-sensitizing with bromodeoxyuridine (BrdU), cells were
micro-irradiated using a 355-nm laser along a track in the nucleus
(“stripe”). We chose these conditions in particular in order to
induce the most pleiotropic range of DNA lesions possible, to avoid
restricting our screen to a particular type of DNA damage.
The first GFP-tagged kinase to demonstrate robust recruitment to
sites of laser micro-irradiation was CDKL5 (Fig 1A). Recruitment of
GFP-tagged CDKL5 to sites of line (Fig 1B) or spot (Fig 1C and D)
micro-irradiation was rapid and transient (Movies EV1 and EV2),
reminiscent of proteins that bind poly(ADP-ribose) chains generated
by DNA damage-activated poly(ADP-ribose) polymerases (PARPs)
(Ahel et al, 2009). Consistent with this idea, CDKL5 recruitment
was blocked by the PARP inhibitors olaparib and talazoparib
(Fig 1B–D) or by PARP1 disruption (Fig 1E); in contrast, retention
time was prolonged by PDD00017273, an inhibitor of poly(ADP-
ribose) glycohydrolase PARG, which delays PAR degradation
(Fig 1B–D; Movies EV1 and EV2) (James et al, 2016). We took an
alternative approach to visualize CDKL5 recruitment and found it to
be retained on damaged chromatin after cells were exposed to H2O2,
a potent inducer of DNA breaks and PARylation (Fig 1F–H). Reten-
tion of CDKL5 on chromatin induced by H2O2 was prevented by
olaparib, whereas the nucleolar retention seen in undamaged cells
was unaffected (Fig 1G and H).
The data above indicate that CDKL5 recruitment to DNA breaks
requires local synthesis of PAR. This may reflect a requirement for
PAR-mediated chromatin relaxation, or alternatively, CDKL5 may
bind PAR directly. Using bioinformatics means, we failed to detect
any of the known PAR-binding motifs (Teloni & Altmeyer, 2016),
and we therefore attempted to pinpoint the recruitment region in
CDKL5 experimentally using a series of overlapping N-terminal and
C-terminal deletion constructs. This revealed a region between
amino acids 530 and 730 necessary for CDKL5 recruitment (Fig 2A
and B); further deletions revealed that the region 530–680 of CDKL5
was sufficient (Fig 2C and D). This region is intrinsically disordered
(Fig EV1B), reminiscent of proteins that undergo liquid de-mixing
when they bind PAR, such as FUS (Altmeyer et al, 2015). Recombi-
nant CDKL5 fragments corresponding to the recruitment region
pinpointed above bound to PAR in vitro (Fig 2E and F), albeit with
a lower apparent affinity than the positive control APLF (Ahel et al,
2008). Accordingly, PAR was detected in CDKL5 precipitates, and
vice versa, after exposure of cells to H2O2 (Fig 2G and H). Taken
together, these data show that CDKL5 is recruited to DNA breaks
in a manner requiring the synthesis of PAR, to which CDKL5 can
bind directly.
CDKL5 recruitment to DNA damage sites requires
ongoing transcription
Although local PAR synthesis is required for CDKL5 recruitment to
DNA damage sites, we discovered unexpectedly the recruitment
mechanism is more complex. We noticed that the transcription inhi-
bitors actinomycin D or a-amanitin, which inhibit RNA polymerases
2 of 25 The EMBO Journal e108271 | 2021 ª 2021 The Authors
























time post damage (min) 































































































time post damage (min)















ª 2021 The Authors The EMBO Journal e108271 | 2021 3 of 25
Taran Khanam et al The EMBO Journal
(RNAPs) I and II, or DRB (5,6-dichloro-1–b-D-ribofuranosyl-
benzimidazole), which blocks RNAP II elongation, abrogated the
recruitment of CDKL5 to micro-irradiation sites (Fig 3A–E); PAR
synthesis and recruitment of the PAR-binding single-strand break
(SSB) repair protein XRCC1 or FAN1 were unaffected under these
conditions. Consistent with the idea that RNA synthesis is required
for CDKL5 recruitment, incubation of permeabilized cells with RNase
A abolished micro-irradiation tracks formed by CDKL5 but did not
affect recruitment of XRCC1 (Fig 3F). Therefore, CDKL5 is recruited
to DNA breaks at sites of active transcription.
A phosphoproteomic screen to identify nuclear targets of CDKL5
The data presented above suggested that nuclear targets of CDKL5
may be involved in transcriptional control, and we speculated that, if
so, the nuclear targets of CDKL5 should include transcriptional regula-
tors. Previous screens for CDKL5 targets identified exclusively cytoso-
lic targets. To identify the nuclear targets specifically, we stably
expressed CDKL5 wild-type (WT) or a K42R kinase-dead (KD) mutant
(Munoz et al, 2018) exclusively in the nucleus of CDKL5-disrupted U–
2–OS cells by adding an artificial nuclear localization signal (NLS).
Immunofluorescence and fractionation experiments confirmed that
the NLS-tagged forms of CDKL5 are predominantly nuclear
(Fig EV2A–C). We next compared the phosphoproteome of these two
cell populations, after exposure to H2O2 to induce PAR-dependent
CDKL5 retention at DNA breaks (Figs 4A and EV2D; Table EV1). Five
biological replicates of each of the two populations (CDKL5NLS WT
cells + H2O2; CDKL5
NLS KD cells + H2O2) were lysed, and Cys resi-
dues were reduced and alkylated. After trypsinization of cell extracts,
phosphopeptides were enriched by chromatography. The 10 samples
were then isotopically labelled with tandem mass tags (TMT), allow-
ing multiplexed and quantitative analysis of all 10 samples, which
were combined and analysed together (Rauniyar & Yates, 2014). The
pooled sample was fractionated into 60 fractions using basic reverse-
phase liquid chromatography. These fractions were then concatenated
into 20 fractions and analysed by LC-MS/MS. Applying a false discov-
ery threshold (FDR) of 5% identified 46,258 unique peptides of which
36,696 had at least one phosphorylation site with a PTM score proba-
bility of ≥ 75%; this yielded 28,185 unique phosphorylation sites.
Normalization and intensity distribution in the TMT channels were
checked and deemed satisfactory (Fig EV3).
In order to identify putative CDKL5 substrates, mass spectromet-
ric data (Table EV1) were subjected to volcano plot analysis as
shown in Fig 4B. This analysis revealed 37 phosphopeptides (31
unique sequences) that were greater in abundance in the CDKL5NLS
WT samples compared with CDKL5NLS KD. This group of 37 clus-
tered away from the bulk of phosphopeptides, and all of the phos-
phopeptides in the cluster had a P-value < 0.0005. Of these 37
phosphopeptides, 22 had a single, unique phosphorylation site
(≥ 75% PTM score probability) and were therefore assigned as
◀ Figure 1. CDKL5 senses DNA damage in a PAR-dependent manner.
A BrdU-sensitized U-2-OS Flp-In T-REx cells stably expressing mCherry-FAN1 and GFP-NLS or GFP–CDKL5 (no NLS) were line-micro-irradiated (355 nm) and imaged
after 2 min. Scale bar is 10 lm.
B BrdU-sensitized U-2-OS cells stably expressing GFP-NLS-CDKL5 were pre-incubated with DMSO (mock), olaparib (5 lM), talazoparib (50 nM) or PDD00017273
(0.3 lM) for 1 h prior to micro-irradiation and live imaged at the indicated times post–irradiation. One of three independent experiments is shown. Scale bar is
10 lm.
C Same as (B) except that cells stably expressing GFP-NLS-CDKL5 were pre-incubated with DMSO (mock), olaparib (5 lM) or PDD00017273 (0.3 lM) for 1 h prior to spot
micro-irradiation (405 nm). Individual cells from one of two independent biological replicates are shown. Scale bar is 10 lm.
D Quantitation of spot intensities. Data represent the mean  SEM of two independent experiments; > 50 micro-irradiated cells per point.
E BrdU-sensitized parental or PARP1D/D, PARP2D/D, PARP1/2D/D U–2–OS cells transiently expressing GFP-NLS-CDKL5 were subjected to 355 nm line micro-irradiation
followed by time-lapse imaging. One of two independent experiments is shown. Scale bar is 10 lm.
F Diagram of the workflow for the chromatin retention experiments.
G Cells subjected to the workflow in (F) were detergent–extracted and fixed before staining with anti-GFP or fibrillarin (nucleoli). Scale bar is 10 lm.
H Quantification of the detergent-insoluble GFP-NLS-CDKL5 signal (minus nucleolar signal). The mean  SD from three biological experiments is shown. Statistical
significance was assessed by one-way ANOVA test. Asterisks ** indicate P-value of < 0.01; ns—not significant.
Source data are available online for this figure.
▸Figure 2. CDKL5 recruitment domain binds PAR directly.A Schematic diagram of CDKL5 deletion mutants, deleting from the N-terminal (blue) or C-terminal (black) ends. All proteins were expressed with an N-terminal NLS
and GFP tag.
B BrdU-sensitized U-2-OS (Flp-In T-REx) cells stably expressing GFP-NLS, the GFP-NLS-CDKL5 deletion mutants shown in (A) or full length (FL) GFP-NLS-CDKL5 was
subjected to line micro-irradiation (355 nm) and time-lapse imaging. Three independent experiments were performed, and one representative experiment is
shown. Scale bar is 10 lm.
C Schematic for fragments corresponding to the PAR-dependent recruitment region in CDKL5 as identified in (B).
D Same as in (B) except that the GFP-NLS-tagged CDKL5 fragments indicated were examined. Scale bar is 10 lm.
E Coomassie gel showing recombinant fragments of human CDKL5 fused to GST purified from bacterial lysates. GST and APLF were also purified as controls.
F Recombinant fragments of CDKL5 fused to GST (1.2, 2.5, 5, 10 μg), or GST, were dot-blotted on nitrocellulose membrane and then incubated with synthetic PAR.
PAR binding was detected by far Western blotting. APLF was used as positive control. One of three independent experiments is shown.
G, H U-2-OS (Flp-In T-Rex) cells stably expressing CDKL5 were either mock-treated or treated with 500 μM H2O2 for 30 min. Extracts were subjected to
immunoprecipitation with antibodies against CDKL5 (G) or PAR (H) (or non-specific IgG as control). Precipitates, and input lysates, were analysed by Western
blotting using the indicated antibodies. One of two independent experiments is shown.
Source data are available online for this figure.
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peptides of interest (Fig 4C). Besides CDKL5 itself, and the previ-
ously identified substrates MAP1S and EB2, our analysis revealed a
range of nuclear proteins as putative CDKL5 targets. Strikingly, the
phospho-acceptor Ser or Thr residue in almost all of the putative
nuclear CDKL5 substrates lies in an extended version of the motif
identified for the cytosolic targets: R–P–X–[S/T]–[A/G/P/S]
(Fig 4C). The R located at the 2 position and the and P located at
1 are known to be essential for Ser/Thr phosphorylation by
CDKL5 (Munoz et al, 2018). To test whether the residues that can
be accommodated at the +1 position in vitro agree with the [A/G/P/
S] amino acid selection identified above, a range of synthetic
peptides based on the sequence around a previously identified
substrate MAP1S Ser900 were synthesized. Two lysine residues were
added at the N-terminus of each peptide to enable binding to P81
phosphocellulose paper, which enabled isolation of peptides at the
end of kinase reactions and quantitation of peptide phosphorylation.
The wild-type peptide sequence was KKRASRPLS900ARSEPSE
(Fig EV2E), and we tested the impact of substituting A901 at the +1
position relative to the S900 phospho-acceptor site for every other
amino acid. As shown in Fig EV2E, the MAP1S Ser900 peptide was
efficiently phosphorylated by FLAG precipitates from extracts of
cells expressing C-terminally FLAG-tagged CDKL5 but not the FLAG-
CDKL5 K42R kinase-dead mutant. We found that A, G and P were
the preferred residues at the +1 position, with the only other amino
acid allowing peptide phosphorylation at greater than 50% of wild-
type levels was S (Fig EV2E). These in vitro data are in good agree-
ment with the motif R-P-X-[S/T]-[A/G/P/S] that shows remarkably
strong enrichment among the putative CDKL5 targets shown in
Fig 4C. These data suggest strongly that R-P-X-[S/T]-[A/G/P/S]
represents a prerequisite consensus motif for CDKL5 target phos-
phorylation and suggest hits from our screen with this motif are
direct targets of CDKL5.
Gene ontology (GO) analysis showed a striking enrichment of tran-
scription regulators (Fig 4D and E). The top three hits from the screen
include EP400, a chromatin-remodelling transcriptional activator
(Pradhan et al, 2016); Elongin A (ELOA), a transcriptional elongation
factor and component of an E3 ligase complex that ubiquitylates
RNAPII (Conaway & Conaway, 2019); ZAP3 (YLPM1), a protein phos-
phatase 1-interacting putative nucleoside kinase that binds to hnRNP-
G and transcriptional co-activators, whose cellular roles are unclear.
Other putative CDKL5 substrates include trichothiodystrophy non-
photosensitive 1 (TTDN1), an uncharacterized protein mutated in a
form of trichothiodystrophy (TTD), typically caused by failure in
transcription-coupled DNA repair (Heller et al, 2015).
We sought to validate EP400, ELOA and TTDN1 as CDKL5
substrates by testing the phosphorylation of these proteins
expressed in HEK293 cells. Extracted ion chromatogram (XIC) anal-
ysis of tryptic phosphopeptides isolated from FLAG-tagged EP400
(pSer729; UniProtKB accession Q96L91), ELOA (pSer311; UniProtKB
accession Q14241) and TTDN1 (pSer40; UniProtKB accession
Q8TAP9) confirmed phosphorylation of these proteins in cells when
co-expressed with wild-type, but not kinase-dead, CDKL5 (Fig 5A–
C). Furthermore, CDKL5 robustly phosphorylated synthetic peptides
corresponding to EP400 Ser729 and ELOA Ser311 demonstrating
direct phosphorylation (Fig 5D). We chose ELOA for further investi-
gation, because it has already been implicated in the DDR (Weems
et al, 2015) and generated antibodies specific for phospho-Ser311 to
further characterize ELOA phosphorylation. Co-expression with
WT, but not KD CDKL5, markedly increased Ser311 phosphorylation
of FLAG-ELOA, but not of an ELOA Ser311Ala mutant (Fig 6A). We
also assessed the impact of CDD-associated CDKL5 mutations,
which are located predominantly in the kinase catalytic domain
(Krishnaraj et al, 2017). As shown in Fig 6B, a series of CDD-
associated mutations severely reduced CDKL5 activity towards
▸Figure 3. CDKL5 recruitment to DNA lesions requires ongoing transcription.A (Top) BrdU-sensitized U-2-OS (Flp-In T-REx) cells stably expressing GFP-NLS-CDKL5 were treated with indicated transcription inhibitors before subjecting to spot
micro-irradiation (405 nm). (Bottom) Quantitation of spot intensities. Data represent the mean  SEM of two independent experiments; > 50 micro-irradiated cells
per point. The “mock” trace shown is identical to the “mock” trace shown in Fig 1D, as the data come from the same set of biological replicates. Scale bar is 10 lm.
B–D BrdU-sensitized U-2-OS (Flp-In T-Rex) cells stably expressing GFP-NLS-CDKL5, mCherry-XRCC1 or mCherry-FAN1 were pre-incubated with indicated transcription
inhibitors prior to line micro-irradiation (355 nm) and time-lapse imaging. One of three independent experiments is shown. Scale bar is 10 lm.
E Same as (B–D) except that BrdU-sensitized cells stably expressing GFP-NLS-CDKL5 were also pre-incubated with olaparib as control. Cells were subjected to line
micro-irradiation, fixed and then subjected to indirect immunofluorescence using antibodies against GFP, PAR and cH2AX. Scale bar is 10 lm.
F Stable cell lines were permeabilized and incubated with RNase A or PBS before irradiation and imaging. Scale bar is 10 lm.
Source data are available online for this figure.
◀ Figure 4. Transcriptional regulators as putative CDKL5 targets.
A Quantitative phosphoproteomic workflow.
B Volcano plot of the mass spectrometric data from the experiment in (A) (see Table EV1).
C List of proteins containing phosphorylation sites more abundant in cells expressing CDKL5NLS WT vs KD, with phosphorylation sites having PTM score probabilities
> 75% (peptides with a 100% PTM score probability are shaded in grey). Phosphorylation sites with a R–P–X–[S/T]–[A/G/P/S] motif are highlighted in red.
D Protein–protein interaction network of putative CDKL5 substrates from Table EV1. Confidence levels are based on the STRING database v11.0 combined score with
following bins: 150–400: low confidence (blue); 400–700: medium confidence (gold); 700–900: high confidence (not encountered in this dataset); and > 900: very
high confidence (black). P-value was calculated as 0.00068.
E Analysis of GO terms. Significance cut-off was set as a = 0.01 with at least three proteins identified in the respective group. GO term enrichment factor expresses the
relative over-representation of the GO term within the group of proteins containing a phosphorylation site that is more abundant in WT compared with KD
compared with the group of all proteins.
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EP400 E1A-binding protein p400 Q96L91 17.12 Ser729 S(0.968) RPSSA
ELOA Elongin-A Q14241 6.65 Ser311 S(1) RPPSG
ZAP3 Nuclear protein ZAP 3 P49750 6.23 Ser1089 S(0.899) PGSSR
CDKL5 Cyclin-dependent kinase-like 5 O76039 5.22 Tyr171 Y(0.993) YTEYV
EB2 Microtubule-associated protein RP/EB family member 2 Q15555 4.80 Ser223 S(0.885) RPSSA
ZAP3 Nuclear protein ZAP 3 P49750 4.42 Ser1088 S(0.877) RPGSS
ZNF592 Zinc finger protein 592 Q92610 3.69 Ser1100 S(1) RPVSG
MAP1S Microtubule-associated protein 1S Q66K74 3.47 Ser900 S(1) RPLSA
SMTN Smoothelin P53814 3.44 Ser139 S(0.986) RPNSG
CLSPN Claspin Q9HAW4 2.95 Ser1246 S(1) RPGSA
HNRNPF Heterogeneous nuclear ribonucleoprotein F P52597 2.70 Thr215 T(1) RPGTA
ZC3H14 Zinc finger CCCH domain-containing protein 14 Q6PJT7 2.58 Thr734 T(0.925) RPQTS
PHF23 PHD finger protein 23 Q9BUL5 2.47 Ser400 S(1) PPKSG
PPP1R26 Protein phosphatase 1 regulatory subunit 26 Q5T8A7 2.41 Thr606 T(0.892) RPSTP
RPL13 60S ribosomal protein L13 P26373 2.29 Ser52 S(1) RPASG
TNRC18 Trinucleode repeat-containing gene 18 protein O15417 2.26 Ser660 S(1) RPESA
ZKSCAN8 Zinc finger protein with KRAB and SCAN domains 8 Q15776 2.22 Ser141 S(1) RPVSA
TCOF1 Treacle protein Q13428 1.90 Ser801 S(1) RAPSA
TTDN1 Tricothiodystrophy non-photosensive 1 protein Q8TAP9 1.84 Ser40 S(1) RPPSP
KIAA1429  Protein virilizer homolog Q69YN4 1.64 Ser1759 S(0.836) RPLSS
CDKL5 Cyclin-dependent kinase-like 5 O76039 1.60 Ser847 S(0.884) HLSSA
RBMX RNA-binding mof protein, X chromosome P38159 1.44 Ser261 S(1) RGYSD
B
Figure 4.
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ELOA-pSer311, whereas a series of benign variants did not (Fig 6B).
Therefore, ELOA phosphorylation is a potential biomarker of CDKL5
activity that may be useful in the clinic.
ELOA recruitment and CDKL5-dependent phosphorylation of
ELOA Ser311 at DNA damage sites require PAR synthesis and
active transcription
We speculated that ELOA might be phosphorylated by CDKL5 at
DNA damage sites, and in this light, we wondered whether ELOA is
recruited to DNA damage sites perhaps by a similar mechanism to
CDKL5. In agreement with this idea, ELOA recruitment to laser
micro-irradiation tracks was rapid, transient and inhibited by
olaparib, a-amanitin and DRB. Similar results were obtained for
other putative CDKL5 substrates such as ZNF592 and ZAP3
(Fig EV4A–C), but not EP400 (data not shown). Strikingly, we
observed CDKL5-dependent phosphorylation of endogenous ELOA
Ser311 at micro-irradiation tracks. Signal intensity was reduced by
depletion of ELOA (Fig 6C) or by incubation of cells with lambda-
phosphatase or the ELOA Ser311 phosphopeptide antigen
(Fig EV4D), thereby confirming antibody specificity. ELOA phos-
phorylation was reduced by disruption or depletion of CDKL5
(Fig 6D and E), or by olaparib or DRB, which block recruitment of
both CDKL5 and ELOA (Fig 6D). These data reveal CDKL5-
dependent phosphorylation of ELOA at DNA damage sites, involving
a common mechanism of recruitment for both kinase and substrate.
Notably, the recruitment of ELOA to micro-irradiation tracks was
not dependent on the phosphorylation of Ser311 as recruitment
appeared normal in CDKL5 knockout cells, and recruitment of an
ELOA S311A mutant was indistinguishable from wild type
(Fig EV4E).
CDKL5 facilitates silencing of transcription near DNA breaks
The ontological enrichment for transcription regulators among the
nuclear CDKL5 substrates suggested a role in transcriptional control
at DNA damage sites. Breaks in genomic DNA are known to silence
adjacent genes (Shanbhag et al, 2010; Pankotai et al, 2012; Gong
et al, 2015), and we therefore tested a role for CDKL5, using two dif-
ferent experimental systems. First, we used a reporter system in
which addition of 4-hydroxytamoxifen (4-OHT) induced nuclear
translocation of mCherry-FokI nuclease, which induces a cluster of
double-strand breaks (DSBs) upstream of a doxycycline-inducible
reporter gene; DSB induction silences the reporter cassette (Fig 7A)
(Shanbhag et al, 2010). We set out to test whether CDKL5 is
recruited to FokI-induced DSB, mindful that it is difficult to capture
transiently recruited PAR-dependent proteins at DSB foci. To
capture CDKL5 recruitment, reporter cells were pre-incubated with
PARG inhibitor, which causes a modest extension in CDKL5 reten-
tion time, and the ATM inhibitor KU455933 to prevent transcrip-
tional silencing; 4-OHT was added for just 15 min to induce FokI.
Under these conditions, between 5 and 20% of cells showed clear
◀ Figure 5. Validating phosphorylation of EP400, ELOA and TTDN1.
A HEK293 cells were co-transfected with CDKL5NLS (wild-type “WT” or kinase-dead “KD” K42R mutant) and either FLAG-EP400 (left), FLAG-ELOA (middle) or FLAG-TTDN1
(right). 24 h later, cells were incubated with H2O2 (500 μM) for 15 min before being harvested and lysed. Protein extracts were subjected to immunoprecipitation
with anti-FLAG-agarose beads. Precipitates were subjected to SDS–PAGE and blotting with antibodies shown (bottom panels) or staining with Coomassie Brilliant
Blue (top panels). The bands corresponding to the FLAG-tagged proteins were excised from the gels in A. and processed for mass spectrometric detection of relevant
phosphopeptides. Three independent co-transfection experiments were done for every condition.
B Boxplots showing VSN-normalized intensity of phosphopeptides corresponding to EP400-pSer729, ELOA-pSer311 and TTDN1-pSer40 from the experiment in (A). The
central band of the boxplot indicates the median value, while the hinges represent the first and third quartile (bottom and top of boxplot, respectively). The whiskers
extend to the largest/smallest (upper or lower whisker, respectively) datapoint not further than 1.5 times the interquartile range from their respective hinge. In all
cases, the data were derived from 3 biological replicates.
C Boxplots of the VSN-adjusted TMT reporter ion intensities for all peptides for each TMT label in the case of FLAG-EP400, FLAG-ELOA and FLAG-TTDN1 from the
experiment in (A). The central band of the boxplot indicates the median value, while the hinges represent the first and third quartile (bottom and top of boxplot,
respectively). The whiskers extend to the largest/smallest (upper or lower whisker, respectively) datapoint not further than 1.5 times the interquartile range from their
respective hinge. Datapoints were further removed, and then, the whiskers are plotted individually. The experiment was conducted using three biological replicates
within each respective group, and each TMT channel represents a single biological replicate.
D Left: Anti-FLAG precipitates from HEK293 cells transiently expressing FLAG-tagged CDKL5 (wild-type “WT” or a K42R kinase-dead “KD” mutant) were incubated with
the synthetic peptides indicated, in the presence of [c-32P]-labelled ATP-Mg2+, and peptide phosphorylation was measured by the Cerenkov counting. Data are
represented as mean  SEM from three independent experiments. Right: Same but anti-FLAG precipitates were subjected to SDS–PAGE and autoradiography to
detect CDKL5 autophosphorylation, or Western blotting with CDKL5-pTyr171 antibody specific for the CDKL5-Tyr171 autophosphorylation site (Munoz et al, 2018).
Source data are available online for this figure.
▸Figure 6. Phosphorylation of ELOA Ser311 by CDKL5 on damaged chromatin.A HEK293 cells were co-transfected with CDKL5 (wild-type “WT” or kinase-dead “KD” K42R mutant) fused to an NLS, and FLAG-ELOA (wild-type “WT” or a S311A
mutant “SA”). Anti-FLAG precipitates or cell extracts were probed with the antibodies indicated. One of three independent experiments is shown.
B Same as (A) showing a range of pathogenic (red) and benign (blue) CDKL5 variants.
C–E Wild-type (WT), CDKL5-disrupted (CDKL5D/D) or siRNA-transfected cells were subjected to indirect immunofluorescence analysis with the indicated antibodies at
laser tracks. Quantification of ELOA-pSer311 signal at the laser tracks is shown. Data represent mean  SD of total pELOA Ser311 intensities in different biological
replicates as indicated (n). For simplicity, only intensities greater than zero are shown. Statistical significance was assessed by one-way ANOVA test or the unpaired
t-test with Welch’s correction. Asterisks **** indicate P-values of < 0.0001. Scale bar is 10 lm.
Source data are available online for this figure.
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mCherry-FokI foci, and around 3–5% cells showed co-localization
of GFP-tagged CDKL5 with mCherry-FokI foci (Fig 7B). Despite the
low proportion of cells displaying GFP-CDKL5 foci, three biological
replicates of this experiment, with multiple technical replicates done
on the same day per biological replicate, yielded similar data. GFP
alone never co-localized with mCherry-FokI. In each experiment,
we included a control where doxycycline was omitted so that tran-
scription of the reporter cassette was off. Under these conditions, no
GFP-CDKL5 foci were observed co-localizing with mCherry-FokI
(Fig 7B). These data suggest (but do not prove) that CDKL5 is
recruited specifically to DSB where there is active transcription. We
noticed that siRNA-mediated depletion of CDKL5 weakens silencing
of the reporter cassette, similar to depletion of ATM or ZMYND8,
which was previously reported to be involved in mediating tran-
scriptional silencing near DNA breaks (Figs 7C and D, and EV5A)
(Shanbhag et al, 2010; Gong et al, 2015).
Next, we took advantage of a system where inducible overex-
pression of the site-specific meganuclease I-PpoI cuts 14–30 times in
the human genome, including active genes such as SLCO5a1 and
RYR2 (Fig 8A) (Pankotai et al, 2012; Caron et al, 2019). As shown
in Fig 8B (left panels), a strong decrease in SLCO5a1 mRNA levels
was observed 2 h after I-PpoI induction, when DSB induction was
maximal (right panels), but mRNA levels returned to basal levels by
8 h consistent with previous reports (Pankotai et al, 2012; Caron
et al, 2019). Strikingly, CDKL5 depletion largely abolished the I-
PpoI-induced silencing of SLCO5a1 (Fig 8B, left panels) but did not
affect either formation or repair of the I-PpoI-mediated DSB at these
loci (Fig 8B, right panels). Ectopic expression of an siRNA-resistant
form of CDKL5 rescued the defect in I-PpoI-mediated silencing of
SLCO5a1 caused by the CDKL5 siRNA, whereas a K42R-mutated
kinase-dead form of CDKL5 did not (Figs 8C and EV5B). Similar
data were obtained for the RYR2 gene known to be silenced by I-
PpoI induction (Fig 8C). Therefore, the kinase activity of CDKL5
facilitates the transcriptional silencing of genes at or close to DSB.
Discussion
In this study, we show that CDKL5 is recruited to DNA damage
induced by laser micro-irradiation and DNA breaks, and the avail-
able data indicate that active transcription is required—transcrip-
tional inhibitors block CDKL5 recruitment to sites of laser micro-
irradiation; pre-incubation of cells with RNase A abolishes CDKL5
signal at laser tracks; CDKL5 does not appear to be recruited to FokI
nuclease-induced DSB without transcription nearby. One interpreta-
tion of these data is that CDKL5 acts as a coincidence detector recog-
nizing breaks (and maybe other DNA lesions) that occur at sites of
active transcription (Fig 8D). CDKL5 recruitment to micro-
irradiation sites is PAR-dependent, and CDKL5 can bind PAR
directly; therefore, the direct binding of CDKL5 to PARP1-generated
PAR may allow detection of DNA breaks. However, the mechanism
whereby CDKL5 detects transcriptional activity remains to be
◀ Figure 7. CDKL5 facilitates transcriptional repression at DNA breaks.
A Cartoon of reporter construct (Tang et al, 2013) in which induction of the mCherry-tagged FokI endonuclease (with 4-OHT) results in double-strand break (DSB) in a
region upstream of a doxycycline-inducible reporter gene (YFP-MS2). Ongoing transcription of the reporter gene can be visualized by the presence of a YFP-MS2
fusion protein that binds stem–loop structures in the nascent transcript.
B CDKL5 is recruited to FokI-induced DSBs. GFP alone (top panel) or GFP-NLS-CDKL5 (middle and bottom panels) was stably expressed in U-2-OS 265 DSB reporter cells.
Cells were mock-treated or treated with 1 μg/ml doxycycline for 3 h to induce transcription of the reporter gene. An hour before DSB induction, cells were treated
with 0.3 μM PARG and 10 μM ATM inhibitor. Site-specific DSBs were induced by treating the cells with 4-OHT and Sheild1 ligand. Cells were live-imaged at 37°C,
between 15 and 25 min following DSB induction. Representative image showing the recruitment of GFP-NLS-CDKL5 to FokI-induced DSBs upstream of
transcriptionally active (middle) but not the inactive (bottom) MS2 gene. GFP alone is used a control (top). White arrowheads mark the location of the mCherry-FokI
upstream of the MS2 reporter cassette. Images are representative of multiple technical replicates of three independent experiments. Scale bar is 10 lm.
C Representative image for U–2–OS 263 IFII cells harbouring the reporter construct and transfected with the siRNAs indicated. After addition of doxycycline,
transcription was monitored in cells  induction of FokI by quantification of YFP(–MS2) foci. Arrows indicate sites of FokI-mediated DSB (mCherry) and YFP-MS2
transcript. “TRXN”: doxycycline added; “TRXN/DSB”: doxycycline added with 4-OHT. Scale bar is 10 lm.
D (Left) Quantification of transcription in U-2-OS 263 IFII reporter cells from experiment in B. > 150 cells were analysed per condition per experiment. The mean  SD
from four independent experiments is shown. (Right) Quantitative RT–PCR analysis of YFP-MS2 mRNA in U-2-OS 263 reporter cells. Data represent mean  SD in
different biological replicates as indicated (n). Statistical significance for all the data was assessed by two-way ANOVA test, **P < 0.01, ***P < 0.001 and
****P < 0.0001; ns—not significant.
Source data are available online for this figure.
▸Figure 8. Kinase activity of CDKL5 facilitates transcriptional silencing.A Schematic diagram of the I-PpoI system for inducing DNA breaks in the nuclear human genome. Addition of 4-OHT to U-2-OS-pEP15 cells stably expressing the I-
PpoI endonuclease fused to the estrogen receptor (ER) induces nuclear translocation of the fusion protein and cleavage cleavage of FokI recognition sites in nuclear
DNA resulting, leading to DSB induction.
B, C Quantitative PCR with reverse transcription (qRT–PCR) analysis of SLCO5a1 (B) and RYR2 expression levels (C) (left panels) U-2-OS HA-ER-I-PpoI cells depleted of
CDKL5 transiently transfected with FLAG-tagged CDKL5 wild-type (WT) or a K42R-mutated kinase-dead (KD) mutant, or empty vector, at the times indicated after
inducing I-PpoI. The mean  SD from two qPCR replicates of two independent experiments is shown. Statistical significance for all the data was assessed by two-
way ANOVA test *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001; ns—not significant. I-PpoI-mediated cutting efficiency in the relevant gene is shown in
the right-hand panel (see Materials and Methods).
D Schematic diagram depicting CDKL5 functions in nucleus and cytosol.
Source data are available online for this figure.
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determined. It was reported that the binding of the central BRCT
domain of XRCC1 to both PAR and DNA is required for recruitment
to DNA breaks (Polo et al, 2019). By analogy, it is tempting to spec-
ulate that binding of the CDKL5 recruitment region to both nascent
RNA and PAR is required for retention at DNA breaks, but more
work is needed to test this idea.
Consistent with a requirement of transcriptional activity for
CDKL5 recruitment to DNA breaks, quantitative phosphoproteomic
screening for nuclear substrates revealed that CDKL5 phosphory-
lates a range of transcriptional regulators including EP400, TTDN1,
ZAP3 and ELOA. In almost all of the hits from our screen, the
phospho-acceptor Ser/Th residues lies in the motif R-P-X-[S/T]-[A/
G/P/S], a motif that our in vitro experiments pointed to indepen-
dently as a CDKL5 consensus motif. Therefore, it is likely that the
hits from our screen are direct targets of CDKL5, and we found that
CDKL5 can directly phosphorylate the relevant site in EP400 and
ELOA. The motif R-P-X-[S/T]-[A/G/P/S] identified in the current
study is likely to represent the definitive CDKL5 consensus motif,
and we predict that proteins lacking such a motif cannot be a direct
substrate of this kinase.
We detected CDKL5-dependent phosphorylation of ELOA
Ser311 at sites of DNA damage that was prevented by inhibitors
of PARP or transcription, which block recruitment of both
CDKL5 and ELOA. These data suggest a model where a common
recruitment mechanism involving PARylation and nascent RNA
synthesis juxtaposes both kinase and substrate at DNA damage
sites, enabling robust phosphorylation of substrate by kinase to
precipitate a local transcriptional response (Fig 8D). It is not yet
clear whether recruitment to DSB also affects the intrinsic activ-
ity of CDKL5 nor is it known whether PAR binding affects
CDKL5 catalytic function. These possibilities will be interesting
to investigate.
The apparent requirement for local transcription in CDKL5
recruitment to DNA breaks, and the enrichment of transcriptional
regulators in the CDKL5 substrate screen, pointed strongly to a role
in modulating transcription at DNA breaks. A well-documented
response to DNA lesions such as double-strand breaks is the silenc-
ing of transcription near the lesion, presumably to facilitate access
to repair proteins and proteins that reset chromatin status before
and after repair (Shanbhag et al, 2010; Marnef et al, 2017;
Tufegdzic Vidakovic et al, 2020). In two different experimental
systems, CDKL5 was found to facilitate the silencing of genes
harbouring DNA breaks (Figs 7 and 8). In particular, the silencing
of active endogenous genes induced by I-PpoI-induced DSB was
affected profoundly by inhibiting CDKL5 kinase activity (Fig 8B
and C). However, the underlying mechanisms are not yet clear,
and it will be important to study which CDKL5 substrates are most
relevant to transcriptional repression at DSB. In a broader context,
it will be important to investigate how phosphorylation affects
CDKL5 substrates such as ELOA, EP400 and TTDN1. As an E3
ligase, ELOA is likely to ubiquitylate a range of proteins at DNA
damage sites, and it is possible this activity, and/or the transcrip-
tional elongation-promoting activity of ELOA, is modulated by
CDKL5. EP400 is a chromatin remodeller important for transcrip-
tional activation, which could be modulated by CDKL5 (Pradhan
et al, 2016). The cellular roles of TTDN1 are unclear, but mutations
in the TTDN1 gene cause a form of trichothiodystrophy (TTD)
referred to as non-photosensitive (NPS) TTD (Nakabayashi et al,
2005; Heller et al, 2015) typified by seizures and symptoms seen in
CDKL5-associated diseases (Heller et al, 2015). Thus, functional
connections between TTDN1, CDKL5 and transcriptional control
will be interesting to pursue.
We are interested in the possibility that CDKL5 controls tran-
scriptional elongation even in the absence of genotoxic insult. The
induction of transient programmed DSBs by topoisomerases I and
II in gene promoters has been linked to the control of transcrip-
tional activity particularly in neurons (Ju et al, 2006; King et al,
2013; Madabhushi et al, 2015). Also, DNA damage-responsive
PARPs have been implicated in transcriptional elongation in cells
that had not been exposed to genotoxic insults (Gibson et al,
2016). Tying these observations together, programmed DNA break-
age in active genes may create a PAR signal that recruits CDKL5
to achieve local phosphorylation of the substrates identified in this
study, leading to the modulation of transcription. A function of
this kind could have a major impact on brain function, which
would help to explain the symptoms of disease caused by muta-
tions in CDKL5 (McKinnon, 2016).
At present, CDD is treated with anti-epileptic drugs, but these
drugs treat the symptoms not the cause of CDD, and most infants
with CDD become refractory within months of starting treatment
(Kadam et al, 2019). Thus, a better rationally designed treatment for
CDD and other CDKL5-related conditions is needed. Most CDKL5
mutations in CDD severely reduce activity towards substrates, but it
is likely CDD is caused by failure to phosphorylate the appropriate
substrates. One possible avenue for the future would be to use cell-
based assays employing phospho-specific antibodies against CDKL5
targets, to screen for small molecules or gene deletions that rescue
phosphorylation of these targets. Such drugs might work by upregu-
lating compensating kinases, other CDKL kinases perhaps, or
inhibiting negative regulators of CDKL5 substrate phosphorylation.
Better tools are needed for screens of this kind, such as rabbit mono-
clonal phospho-specific antibodies against ELOA or EP400, which




All reagents including antibodies, cDNA clones, oligonucleotides and
peptides used in the present study are enlisted in Table EV2. All cDNA
clones and antibodies generated in-house, and datasheets for each
plasmid, can be requested via the MRC-PPU Reagents and Services
reagents website at the following link: https://mrcppureagents.
dundee.ac.uk/reagents-from-paper/rouse-CDKL5-paper-3.
ELOA phospho-Ser311 antibodies
ELOA-pSer311 antibodies were raised by MRC-PPU Reagents and
Services at the University of Dundee in sheep and purified against
the relevant antigen: (DA081; 3rd bleed; raised against the peptide
KEENRRPPS*GDNARE conjugated to bovine serum albumin).
Sheep were immunized with the peptide antigen followed by four
further injections 28 days apart, with bleeds taken seven days after
each injection.
ª 2021 The Authors The EMBO Journal e108271 | 2021 15 of 25
Taran Khanam et al The EMBO Journal
Cell lines and cell culture
All cells were kept at 37°C under humidified conditions with 5%
CO2. HEK293, HEK293FT and U-2-OS Flp-In T-REx, U-2-OS 263 IFII
reporter cells and U-2-OS 265 reporter cells were grown in Gibco
DMEM (Life Technologies, Paisley, UK) supplemented with 100 U/
ml penicillin, 100 μg/ml streptomycin, 1% (v/v) l-glutamate
(GIBCO, Invitrogen), 1% (v/v) sodium pyruvate and 1% (v/v)
non-essential amino acids, 10% (v/v) foetal bovine serum or
10% (v/v) TET System-approved FCS for U–2–OS reporter cell
lines (631106; Takara Bio). U-2-OS-pEP15 cells (Caron et al, 2019)
were maintained in 1 mg/ml glucose phenol red-free DMEM
(Lonza) supplemented with steroid-free FBS (Thermo Fisher Scien-
tific), 1% antibiotic–antimycotic (Sigma-Aldrich), GlutaMAXTM-I
(Gibco) and 800 μg/ml G-418 (Sigma-Aldrich). U-2-OS (Flp-In
T-REx) cells were maintained in 10 μg/ml blasticidin. Hygromycin
(100 μg/ml) or puromycin (2 μg/ml) was used to select for the
integration of constructs in Flp-In recombination sites. All cell lines
were regularly tested for mycoplasma contamination. U-2-OS
Flp-In T-REx CDKL5D/D cells were described previously (Munoz
et al, 2018).
Cell transfections
HEK293 cells were transfected using the calcium phosphate transfec-
tion protocol as previously described (Munoz et al, 2018). Cells
were seeded at a confluence of 20–30% in 15-cm plates and 24 h
later were co-transfected with a total of 10 μg of plasmid
(5 μg + 5 μg in the case of plasmid co-transfection). Cells were
incubated with the transfection mixture for 24 h before being
harvested and lysed.
For transient expression of GFP-tagged proteins in U-2-OS cells,
cells were transfected with 1–2 μg of pcDNA5 FRT/TO plasmids
using GeneJuice Transfection Reagent (Millipore) onto 1 × 105
adhered U-2-OS or U-2-OS Flp-In T-Rex cells in 2 ml media in a 3.5-
cm glass-bottom dish (FD35-100, WPI). 8 h following transfection,
cells were incubated overnight with 0.5–1 μg/ml tetracycline
hydrochloride to induce expression of the target protein.
For siRNA-mediated knockdown of proteins, cells were trans-
fected with a 100 nM suspension of relevant siRNA duplexes (Euro-
fins or Dharmacon) or siRNA SMARTpools (Dharmacon) using
Lipofectamine RNAi-MAX transfection reagent (13778150, Invitro-
gen, Paisley, UK) as per manufacturer’s guidelines. Cells were anal-
ysed for 60–72 h following transfection. siRNA sources and
sequences are outlined in Table EV2.
Generation of stable cell lines using the Flp-In T-REx system
To generate U–2–OS (Flp-In T-REx) cells stably expressing target
proteins, cells were co-transfected with 9 μg of POG44 Flp-
recombinase expression vector (Thermo Fisher) and 1 μg of
pcDNA5 FRT/TO-target protein, using GeneJuice Transfection
Reagent (Millipore). 48 h following transfection, cells were selected
in the presence of 100 μg/ml hygromycin and 10 μg/ml blasticidin
in the medium. Around 10–12 days later, surviving colonies were
pooled together and resulting cultures were analysed for the expres-
sion of target protein following induction with increasing amounts
of tetracycline hydrochloride (T3383; Sigma-Aldrich).
Retrovirus production and target cell infection for the
constitutive expression of target proteins
To generate cells stably expressing nucleus-restricted CDKL5
(NM_003159.2 with silent changes t996c and t2118c), CDKL5D/D
cells (Munoz et al, 2018) were infected with retroviruses expressing
wild-type CDKL5 with an exogenous nuclear localization signal
(CDKL5NLS WT), a kinase-dead (K42R) CDKL5NLS KD or an empty
vector. Similarly, GFP-NLS-CDKL5 or GFP alone was stably
expressed in U-2-OS 265 reporter cells by retroviral transduction.
Briefly, HEK293FT cells were transfected with respective expression
plasmid constructs along with the GAG/Pol and VSVG constructs
required for retroviral production, using calcium phosphate trans-
fection protocol as previously described (Munoz et al, 2018). 48 h
following transfections, retrovirus-containing medium from the cell
dish was collected, filtered and applied along with polybrene (8 μg/
ml) to the target cells for 24 h. Medium was replaced with fresh
medium containing appropriate selection antibiotic for another
36 h. Surviving cells were pooled together, and successful retrovirus
integration is confirmed though Western blotting. A list of plasmid
constructs is included in Table EV2.
Whole-cell extract preparation and Western blotting
Cell pellets were lysed on ice for 30 min in ice-cold lysis buffer
(50 mM Tris–HCl (pH 7.4) buffer containing 0.27 M sucrose,
150 mM NaCl, 1% (v/v) Triton X-100, 0.5% (v/v) Nonidet NP-40
and 0.1% (v/v) 2-mercaptoethanol) supplemented with a protease
inhibitor cocktail (cOmpleteTM, EDTA-free Protease Inhibitor Cock-
tail), benzonase (Novagen, 50 U/ml) and microcystin-LR (catalogue
number: 33893, Sigma) at a final concentration of 10 ng/ml and
phosphatase inhibitor cocktail-2 (P5726; Merck) at 1% (v/v). The
lysate was cleared by centrifugation at 17,000 g for 15 min, and the
supernatant was collected for protein measurement by the Bradford
assay and stored at 80°C. For Western blotting, the whole-cell
extract (40 μg) was mixed with LDS–PAGE sample buffer (Thermo
Fisher) containing 5% (v/v) 2-mercaptoethanol before boiling at
95°C. Samples were resolved by 4–12% Bis–Tris SDS–PAGE gradi-
ent gels (NuPAGE, Thermo Fisher) followed by transfer onto a
Hybond C Extra Nitrocellulose Membrane (GE1060000; GE Health-
care) for 105 min at 100 V. The membrane was blocked in 5% (w/
v) non-fat dry milk in TBS–Tween-20 (0.2% v/v) for 1 h and probed
with diluted primary antibodies. The membrane was washed three
times in TBS–Tween-20 (0.1%(v/v)), incubated with secondary
antibodies diluted in blocking buffer for 1 h, and washed three
times in TBS–Tween-20 (0.1% (v/v)) prior to developing the
membrane using SuperSignalTM West Pico PLUS Chemiluminescent
Substrate (Thermo) and capturing the signal on an X-ray film. See
Table EV2 for antibody and dilution information.
Subcellular fractionation
Subcellular fractionation experiments were performed using the
Thermo Fisher Subcellular Protein Fractionation Kit for Cultured
Cells (catalogue number: 78840). Briefly, 15-cm plates of cells were
washed with PBS and cells harvested using trypsin–EDTA solution.
Cell pellets were washed twice with ice-cold PBS and then resus-
pended in 500 μl of CEB buffer. Fractionation was subsequently
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done following the manufacturer’s instructions and using the
following amounts of each one of the buffers: 500 μl of MEB buffer
and 250 μl for all the other buffers. Protein concentration in each
fraction was measured, and samples were resuspended in LDS
sample buffer and boiled before being subjected to SDS–PAGE.
In vitro peptide phosphorylation reactions
HEK293 cells were transiently transfected with either wild-type or
kinase-dead (K42R) CDKL5-FLAG-expressing constructs, and 48 h
later, plates were washed in cold PBS and lysed in ice-cold buffer
(50 mM HEPES (pH 7.5), 1% (v/v) Triton X-100, 0.27 M sucrose
and 300 mM NaCl) freshly supplemented with protease inhibitor
cocktail (cOmpleteTM, EDTA-free), 10 mM iodoacetamide, 10 ng/ml
microcystin-LR, 2% (v/v) phosphatase inhibitor cocktail-2 (Sigma-
Aldrich) and 500 U/ml universal nuclease. Lysates were then
cleared by centrifugation for 10 min at 20,000 g at 4°C, and protein
concentration was measured. Extracts (˜ 2.0 mg) were then incu-
bated with 10 μl (settled) anti-FLAG agarose M2 affinity beads
(Sigma-Aldrich) for 2 h at 4°C. Beads were washed five times in
lysis buffer containing 1 M NaCl and then twice in kinase buffer
(50 mM Tris 7.5, 10 mM MgCl2, and 0.1 mM EGTA). Beads were
resuspended in 15 μl kinase buffer containing 0.15 mM peptide
substrate and 0.1% (v/v) 2-mercaptoethanol. Reactions were initi-
ated with the addition of 5 μl [c-32P]-ATP (0.1 mM), incubated for
30 min at 30°C with constant shaking and stopped by adding 10 μl
of 0.5 M EDTA. Samples were centrifuged at 20,000 g, and super-
natants (30 μl) were spotted onto P81-phosphocellulose paper.
Papers were then washed 5 times in 75 mM orthophosphoric acid,
once in acetone, and dried. 32P incorporation in each sample was
measured by the Cerenkov counting using a PerkinElmer TriCarb
scintillation counter. Beads were resuspended in LDS sample buffer,
boiled and subjected to SDS–PAGE followed by Coomassie staining.
Laser micro-irradiation
“Line” micro-irradiation
Around 1 × 105 cells expressing fluorescently tagged proteins of
interest were seeded in 3.5-cm glass-bottom dishes (FD35-100 for
24 h in media containing 10 μM bromodeoxyuridine [BrdU–Sigma]
and 0.5–1 μg/ml tetracycline hydrochloride [Sigma]). Shortly prior
to irradiation, cells were washed with PBS and the medium was
replaced with warm, low absorption medium (31053; Thermo).
Cells were placed in an incubator chamber at 37°C with 5% CO2
supplementation mounted on a Leica TCS SP8X microscope system
(Leica Microsystems). Laser micro-irradiation was performed using
a protocol adapted from Mistrik et al (2016). Briefly, a striation
pattern was generated by scanning bidirectionally at either 16 × 16
or 32 × 32 pixel resolution using a 355-nm laser (coherent), result-
ing in a pattern of 16 or 32 horizontal lines across the imaging field.
The laser dose was adjusted by altering the laser scanning speed
and the number of scanning iterations per line. Typically, irradiation
was performed by scanning at 5 Hz with three iterations per line.
The power at the objective (approximately 1.5 mW) was measured
using a power meter (Thorlabs). Using the above settings, we typi-
cally irradiated at approximately 1.4–2.8 J/m2. Laser micro-
irradiation experiments were performed using a Leica HC PL APO
CS2 63×/1.20 water objective, using a predefined imaging template
utilizing the “Live Data Mode” module within the Leica LASX soft-
ware. After software-mediated autofocus, a pre-irradiation image
was recorded, followed by 355-nm laser micro-irradiation. Time-
lapse imaging was performed following the field of view every 30 s
for 5–10 min. Pre- and post-irradiation images were taken at
1,024 × 1,024 pixel resolution, scanning at 467 Hz, taking eight 1-
μm optical sections per image with 2× averaging. Pre- and post-
irradiation images were stitched using an ImageJ macro and used
for visualization and analysis.
“Spot” micro-irradiation
Cells were prepared for imaging as described above. Cells were
placed in an environmental chamber at 37°C with 5% CO2 attached
to an Axio Observer Z1 spinning disc confocal microscope (Zeiss).
Micro-irradiation was performed using a single-point scanning
device (UGA-42 Firefly, Rapp OptoElectronic). Single-point regions
of interest (ROI) were defined for each cell and irradiated with
100% 405-nm laser power for 600 iterations after removal of the ND
filter. The estimated power delivered per ROI on average was
approximately 27 J/m2. ROI x–y co-ordinates were recorded and
used for subsequent image analysis. A predefined imaging template
was used within the Zen Blue acquisition software. A pre-irradiation
image was recorded, followed by 405-nm irradiation. A time lapse
was subsequently performed every 5 s for 10 min. Hardware autofo-
cus (Definite Focus, Zeiss) was used to ensure focus was maintained
throughout the time lapse and was applied every 70 frames. To
avoid image acquisition during laser micro-irradiation, a 3-s delay
was applied from the start of micro-irradiation and the beginning of
the time lapse. Images were acquired using a C13440 camera
(Hamamatsu), using a C Plan APO 64×/1.40 oil objective, acquiring
4× 0.5 μm optical sections per image with 4 × 4 binning.
Image analysis
Recruitment to sites of spot micro-irradiation was quantified using
CellTool by modifying analysis protocol adapted from Aleksandrov
et al (2018). Briefly, pre- and post-irradiation images were first
stitched using an ImageJ macro. Maximum intensity projections of
the stitched images were then taken. Individual cells were manually
cropped from the original image, and a 5 x5 Gaussian blur filter
was applied to minimize the impact of noise on subsequent image
processing. Micro-irradiated spots were then tracked using the spot
detector /track module within CellTool. Recruitment was calculated
as the difference between the average intensity in the recruitment
region and in a nearby region, multiplied by the total area of recruit-
ment. For negative results, where the protein of interest was not
recruited, ROI co-ordinates were imported to CellTool and the maxi-
mum recruitment within the static ROI was determined, as
described above.
Drug treatment
PARP inhibitors olaparib (S1060; Selleck Chem) and talazoparib
(S7048; Selleck Chem) and PARG inhibitor PDD00017273 (5952;
Tocris Bioscience) were used at a final concentration of 5 μM,
50 nM and 0.3 μM, respectively, and were added to the cells 1 h
prior to and during micro-irradiation. Transcription inhibitors were
employed as follows: a-amanitin (20 μg/ml) for 8 h; DRB (100 μM)
for 2 h; and actinomycin D (5 nM and 2.5 μM) for 40 min prior to
and for the entire duration of micro-irradiation. For RNase
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treatment, cells were first washed with warm PBS and permeabi-
lized with Tween-20 (1% (v/v)) in PBS for 5 min followed by treat-
ment with 1 mg/ml RNase A (Thermo) for 10 min at room
temperature (RT). Following the respective treatments, cells were
micro-irradiated and imaged immediately.
Immunofluorescence
Cells grown on coverslips were washed twice with cold PBS and
fixed with 4% paraformaldehyde (sc-281692, Santa Cruz) in PBS for
15 min at RT. After fixation, cells were washed twice with PBS and
permeabilized with 0.5% (v/v) Triton X-100 (in PBS) for 15 min at
RT, washed twice with PBS and blocked for at least 1 h in antibody
dilution buffer (1× PBS containing 5% normal donkey serum, 0.1%
(v/v) fish skin gelatine, 0.1% (v/v) Triton X-100, and 0.05% (v/v)
Tween-20). Incubation with the relevant primary antibody (over-
night at 4°C) was followed by three washes (5 min in PBS + 0.05%
(v/v) Tween-20) and incubation with appropriate fluorescently
labelled secondary antibody (60 min, RT). Coverslips were washed
three times (5 min in PBS + 0.05% (v/v) Tween-20), stained with
DAPI (Sigma; 1 μg/ml in PBS, 5 min) and mounted using ProLong
Gold antifade mounting agent (P36934; Thermo).
To measure chromatin retention of CDKL5 after oxidative DNA
damage, U-2-OS Flp-In T-REx cells expressing GFP-NLS or GFP-NLS-
CDKL5 were grown on coverslips in media containing 1 μg/ml tetra-
cycline. After 18 h, cells were pre–incubated with PDD00017273
(0.3 μM; “PARGi”) either in the absence or presence of PARP inhi-
bitor olaparib (15 μM) for 60 min before exposing the cells to
hydrogen peroxide (H1009; Sigma; 500 μM) for 30 min. Cells were
then washed twice with cold PBS (containing 0.3 μM PARGi) and
pre-extracted in cold 0.2% (v/v) Triton X-100 (in PBS containing
0.3 μM PARGi) for 4 min at room temperature prior to fixation as
above. Imaging of fixed samples was carried out on a Leica TCS SP8
MP microscope using oil immersion objective (HPA CL APO CS2
63×/1.40 Oil). Quantification of detergent-insoluble anti-GFP signal
(excluding nucleolar GFP signal) from > 150 cells per sample per
repeat was done using Fiji ImageJ-based macro. Non-nucleolar anti-
GFP fluorescence signal was quantified in the region co-localizing
with DAPI but excluding the nucleolar region defined by fibrillarin
co-labelling. Mean nuclear GFP fluorescence was plotted relative to
that in untreated WT cells. Data were plotted and analysed by
GraphPad Prism v9.0.0 using one-way ANOVA followed by the
Bonferroni multiple comparison test.
To examine Ser311 phosphorylation of endogenous ELOA at sites
of laser micro-irradiation, 1 × 105 U-2-OS Flp-In T-REx cells (wild
type, CDKL5 disrupted (CDKL5D/D) or cells pre-depleted with
indicated siRNA for 48 h) were seeded onto 8-well chamber
slides (Ibidi), 24 h prior to the experiment, in media containing
10 μM bromodeoxyuridine (Sigma). 0.3 μM PARG inhibitor
(PDD00017273) was added to cells 30 min before the irradiation.
Nuclei were irradiated as described previously. The cells were pre-
extracted with cold 0.2% (v/v) Triton X–100 (in PBS) for 2 min at
RT and washed twice with cold PBS. Cells were fixed with 4%
paraformaldehyde in PBS for 10 min at RT. After fixation, cells were
washed twice with PBS and permeabilized with 0.2% (v/v) Triton
X-100 (in PBS) for 5 min at RT, washed twice with PBS and blocked
for 45 min in antibody dilution buffer (1× PBS containing 5% (v/v)
normal donkey serum, 0.1% (v/v) fish skin gelatine, 0.1% (v/v)
Triton X-100 and 0.05% (v/v) Tween-20). Fixed, permeabilized cells
were incubated with ELOA-pSer311 antibody (0.32 μg/ml antibody
pre-mixed with 4.8 μg/ml of the corresponding non-phosphopeptide
for 12 h at 4°C overnight, followed by three washes [5 min in
PBS + 0.05% (v/v) Tween-20] and incubation with appropriate flu-
orescently labelled secondary antibody [60 min, RT]). Cells were
washed three times (5 min in PBS+0.05% (v/v) Tween-20), stained
with DAPI (1 μg/ml in PBS, 5 min) and mounted using ProLong
Gold antifade mounting agent. The buffers used in each step were
supplemented with 1% (v/v) phosphatase inhibitor cocktail-2 and
PhosSTOP (Roche: 1 tablet per 10 ml). Imaging of fixed samples
was carried out on a Leica TCS SP8 MP microscope using oil immer-
sion objective (HP CL APO CS2 63×/1.40 Oil). Treatment with
olaparib and DRB was done prior to irradiation as explained before.
To confirm the phosphospecificity of the ELOA-pSer311 antibody,
fixed and permeabilized cells were (i) mock-treated or treated with
100 U lambda-phosphatase (NEB) overnight at 30°C prior to
primary antibody incubation and (ii) incubated with 0.32 μg/ml of
the phospho-specific antibody that had been pre-mixed with 6.4 μg/
ml of the relevant phosphopeptide antigen for 12 h at 4°C.
Quantification of ELOA-pSer311 to DNA damage sites was
performed using a CellProfiler image analysis pipeline. After
segmentation and cropping of individual nuclei, micro-irradiation
tracks delineated by PAR were segmented. Within each nucleus, the
background nuclear intensity outside the segmented tracks was
subtracted from the mean intensity from all detected irradiation
tracks. Data were plotted and analysed by GraphPad Prism v9.0.0
using one-way ANOVA followed by Dunnett’s multiple comparison
test or the unpaired t-test with Welch’s correction. The image analy-
sis scripts are available on request.
Recombinant protein expression and purification
Escherichia coli BL21 codon plus (DE3) cells transformed with
expression plasmids encoding GST-tagged CDKL5 fragments (530–
730, 530–680, 530–630, 530–580), or GST alone or His6-APLF were
grown in Luria Broth (LB) medium containing 100 μg/ml ampicillin
to A600 0.5, followed by 0.5 mM isopropyl b-D-thiogalactopy-
ranoside (IPTG) induction in early log phase for 16 h at 20°C. Cells
were harvested by centrifugation at 3,500 g, and pellets were resus-
pended in lysis buffer (50 mM Tris–HCl pH 7.5, 150 mM NaCl,
5 mM DTT, 5 mM EDTA, 1 mM PMSF and 0.2 mg /ml lysozyme,
25 units Universal nuclease [PierceTM Universal Nuclease for Cell
Lysis], and left on ice for 30 min followed by brief sonication on ice
[five cycles of 30 s on, 30 s off at 30% amplitude]). The homoge-
nate was centrifuged at 20,000 g for 30 min at 4°C, and the clarified
cell lysates were applied to respective affinity resin columns. (i) The
clarified cell lysates from cells overexpressing GST-fusion proteins
were applied to glutathione-Sepharose resin pre-equilibrated with
equilibration buffer (50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 5 mM
DTT and 5 mM EDTA, and 0.1% (v/v) Triton X-100). The column
was washed five times with equilibration buffer and twice with
equilibration buffer without detergent. The GST-fusion proteins
were eluted with 20 mM reduced glutathione in 50 mM Tris–HCl,
pH 7.5, 150 mM NaCl, 10% (v/v) glycerol, 1 mM DTT and 5 mM
EDTA. (ii) The clarified cell lysates obtained from cells overexpress-
ing His6-APLF were applied to Ni-NTA resin pre-equilibrated with
equilibration buffer (50 mM Tris–HCl, pH 7.5, 150 mM NaCl and
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5 mM DTT, 0.1% (v/v) Triton X-100 and 10 mM imidazole). The
column was washed five times with equilibration buffer and twice
with equilibration buffer without detergent. The His6-APLF was
eluted using 300 mM imidazole in 50 mM Tris–HCl, pH 7.5,
150 mM NaCl, 10% (v/v) glycerol and 1mM DTT. Eluted proteins
were dialysed overnight at 4°C in sucrose buffer (50 mM Tris–HCl,
pH 7.5, 150 mM NaCl, 270 mM sucrose, 0.1 mM EGTA, 0.03% (v/
v) Brij-35 and 0.1% (v/v) b-mercaptoethanol). The proteins were
concentrated, snap-frozen and stored at 80°C for further use.
In vitro poly(ADP-ribose) binding assay
Serial dilutions (10, 5, 2.5 and 1.25 μg) of GST, GST-CDKL5 frag-
ments and His6-APLF were dot–blotted onto an activated nitrocellu-
lose membrane under low vacuum conditions. The membranes
were dried and stained with Ponceau S to check loading. The
membrane was washed and blocked with 5% (w/v) skimmed milk
powder in PAR-binding buffer (20 mM Tris–HCl, pH 7.5, and
50 mM NaCl) for 1 h prior to incubation with 50 nM synthetic PAR
(Trevigen; in blocking buffer, 45 min, RT). The membrane was
washed twice with PAR-binding buffer followed by incubation with
primary antibodies (rabbit anti-PAR polyclonal; Trevigen, 1:5,000 in
blocking buffer, 4°C, overnight) and secondary antibodies (goat
anti-rabbit HP-conjugated; Thermo, 1:5,000 in milk, 1 h, RT). PAR-
binding buffer was used to rinse the membrane three times after
each antibody incubation. The membrane was developed using
SuperSignalTM West Pico PLUS Chemiluminescent Substrate
(Thermo), and the resulting signal was captured on an X-ray film.
Immunoprecipitation: CDKL5 binding to PAR in cells
U-2-OS Flp-In T-REx cells stably expressing CDKL5 were mock-
treated or treated with H2O2 (500 μM; 30 min) in the presence of
PDD00017273 (0.3 μM). CDKL5 was immunoprecipitated from
2 mg extract using anti-CDKL5 antibody (S957D); sheep IgG (31243,
Thermo) was used as control. Cells were lysed in 50 mM Tris–HCl
(pH 7.4) buffer containing 0.27 M sucrose, 150 mM NaCl, 1% (v/v)
Triton X-100, 0.5% (v/v) Nonidet NP-40 and 0.1% (v/v) 2-
mercaptoethanol supplemented with a protease inhibitor cocktail
(cOmpleteTM, EDTA-free Protease Inhibitor Cocktail), benzonase
(Novagen, 50 U/ml), 10 ng/ml microcystin-LR (33893; Sigma),
phosphatase inhibitor cocktail-2 (P5726; Merck) at 1% (v/v),
0.3 μM PARGi PDD00017273 (5952; Tocris bioscience) and 5 μM
PARPi olaparib. Extracts were then incubated for 30 min at 4°C and
clarified by centrifugation at 17,000 g in a refrigerated centrifuge.
Clarified extracts were pre-cleared using DynaBeads Protein G
(10003D; Life Technologies) conjugated with sheep IgG isotype
control using the manufacturer’s protocol, for 45 min at 4°C. Pre-
cleared extracts were used to immunoprecipitate CDKL5 using sheep
polyclonal CDKL5 antibodies or sheep IgG isotype control with
DynaBeads Protein G. Approximately 2 μg of anti-CDKL5/sheep IgG
isotype control was linked to beads to perform pull down from 2 mg
of pre-cleared extracts for 2 h at 4°C. Alternatively, pre-cleared
extracts (2 mg) were incubated for 4 h at 4°C with 2 μg of pan-
ADP-ribose binding reagent (MABE1016; Merck) or normal rabbit
IgG (2729S; Cell Signaling) conjugated to DynaBeads Protein G.
Beads were washed three times with lysis buffer and twice in cold
PBS before boiling at 95°C in LDS–PAGE sample buffer (Thermo
Fisher) containing 5% (v/v) 2-mercaptoethanol. Samples were
resolved in 4–12% Bis–Tris SDS–PAGE gradient gels (NuPAGE,
Thermo Fisher). Input lysates or immunocomplexes were analysed
by Western blotting using sheep polyclonal anti-CDKL5, pan-ADP-
ribose binding reagent and anti-GAPDH (14C10; Cell Signaling) anti-
bodies. Antibodies were diluted in 5% (w/v) skimmed non-fat dry
milk in TBS–Tween-20 (0.2% v/v). Membranes were incubated
overnight at 4°C or 2 h at RT with the relevant antibodies, then
washed. Membranes were then incubated with recombinant protein
G-HP (1: 2,500; ab7460) for 1 h at RT. The membrane was devel-
oped using SuperSignalTM West Pico PLUS Chemiluminescent
Substrate (Thermo), and the resulting signal was captured on an
X-ray film.
Phosphoproteomic screening for nuclear substrates of CDKL5
Twenty 15-cm plates of CDKL5-disrupted U-2-OS cells (CDKL5D/D)
expressing CDKL5NLS WT or CDKL5NLS K42R were grown to around
70% confluence, treated with H2O2 (500 μM for 15 min), washed
twice with PBS and harvested in 4 ml of ice-cold solution containing
20% (v/v) TCA, 80% (v/v) acetone and 0.2% (w/v) DTT, trans-
ferred into 5-ml Eppendorf tubes and stored at 20°C overnight.
Samples were then centrifuged twice at 20,000 g, 10°C for 20 min,
and supernatants were then discarded. Pellets were resuspended
with 2 ml ice-cold 80% (v/v) acetone and then centrifuged again at
20,000 g at 10°C for 30 min. After removing the supernatants
completely, pellets were left to air-dry for 10 min.
TCA/acetone-precipitated pellets were resuspended in 500 μl
8 M urea, 50 mM AmBiC, 1% (v/v) phosphatase inhibitor cocktail-
2, 0.1% (v/v) microcystin, pH 8.0 and benzonase at a concentration
of 0.2% (v/v) and incubated for 15 min at room temperature, and
finally lysed using a Bioruptor sonicator. Lysates were centrifuged
at 20,000 g for 30 min at RT and stored at 80°C for further mass
spectrometric analysis. Five independent biological replicates were
carried out, on different days.
Protein concentrations were determined using a BCA assay kit,
and the absorbance was measured at 560 nm. A total of 5 mg
protein from each sample was reduced with 5 mM DTT at 45°C for
30 min, alkylated with 10 mM iodoacetamide at room temperature
in the dark for 20 min, quenched by addition of 5 mM DTT,
digested with Lys–C (1:200 (w/w), LysC:protein) for 4 h at 30°C
and then diluted with 50 mM ammonium bicarbonate to 1.5 M final
urea concentration, followed by trypsin digestion (1:50 (w/w),
trypsin: protein) at room temperature overnight. 1% TFA (v/v) was
added to stop the digestion. The acidified digests were centrifuged
at 10,000 g for 10 min. The collected supernatants were then
desalted on 200 mg Sep–PAK tC18 cartridges, and the eluents were
dried by speed vacuum centrifugation (Thermo). Desalted peptides
were resuspended in 1 ml of 2 M lactic acid and 50% (v/v) acetoni-
trile (ACN) and centrifuged at 15,000 g for 20 min. Supernatants
were transferred to an Eppendorf tube containing 18 mg of titanium
dioxide (TiO2) beads (GL sciences, Japan) and vortex-mixed for 1 h
at room temperature. The TiO2 beads were washed two times
(10 min per wash) with 2 M lactic acid and 50% (v/v) ACN
followed by three washes with 0.1% (v/v) TFA and 50% (v/v)
ACN. Phosphopeptides were eluted twice with 150 μl of 10% (v/v)
ammonia solution (NH4OH) and were finally eluted with 150 μl of
50% (v/v) ACN and 5% (v/v) ammonia solution (NH4OH). The
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combined eluent was dried with vacuum centrifugation and then
cleaned up using in-house-made C18 StageTips (3 M EmporeTM). 1%
of each TiO2-enriched sample was analysed by mass spectrometry
prior to following processes.
TMT10plex labelling was performed according to the manufac-
turer’s protocol using the TMT Labeling Kit. Briefly, the TiO2-
enriched sample was resuspended into 100 μl of 100 mM TEAB. A
total of 0.4 mg of each TMT tag was used for labelling each sample.
After 1-h incubation, 2 μl of each labelled sample was diluted with
18 μl of 0.1% formic acid and was then checked for TMT labelling
efficiency. After checking the labelling efficiency, each TMT-labelled
sample was quenched by incubation with 8 μl of 5% (w/v) hydrox-
ylamine for 30 min at RT. The quenched samples were then mixed
and fractionated with high pH reverse-phase C18 chromatography
using the Ultimate 3000 high-pressure liquid chromatography
system (Dionex) at a flow rate of 569 μl/min using two buffers:
buffer A (10 mM ammonium formate, pH 10) and buffer B (80%
ACN, 10 mM ammonium formate, pH 10). Briefly, the desalted
TMT-labelled samples were resuspended in 200 μl of buffer A
(10 mM ammonium formate, pH10) and fractionated on a C18
reverse-phase column (4.6 × 250 mm, 3.5 μm, Waters) with a
gradient as follows: 3% buffer B to 12.5% buffer B in 5 min, 12.5%
to 40% buffer B in 35 min, 40% B to 60% B in 15 min, 60% B to
100% B in 5 min, 100% for 5 min, ramping to 3% B in 5 min and
then 3% for 10 min. A total of 60 fractions were collected and then
concatenated into 20 fractions, which were further desalted
over C18 StageTips and speed vacuum-dried prior to LC–MS/MS
analysis.
LC–MS/MS mass spectrometry
LC–MS/MS analysis was performed with an Orbitrap Fusion Lumos
(Thermo), with a Thermo Dionex Ultimate 3000RSLC nano-liquid
chromatography instrument. Peptide concentration from each frac-
tion was quantified by Nanodrop, samples were dissolved in 0.1%
formic acid, and 1 μg of each fraction was loaded on C18 trap
column with 3% (v/v) ACN and 0.1% (v/v) TFA at 5 μl/min flow
rate. Peptides were separated over an EASY-Spray column (C18,
2 μm, 75 μm × 50 cm) with an integrated nano-electrospray emitter
(flow rate 300 nl/min). Peptide separation was done over 180 min
with a segmented gradient applying following buffer system: buffer
A: 0.1% (v/v) formic acid; and buffer B: 80% (v/v) acetonitrile and
0.08% (v/v) formic acid. The first seven fractions started from 6 to
35% buffer B for 120 min (note: the following seven fractions
started from 8% and the last six fractions started from 10%), 35–
45% buffer B for 30 min, 45–95% buffer B for 5 min and 95%
buffer B for 5 min. Eluted peptides were analysed on an Orbitrap
Fusion Lumos (Thermo Fisher Scientific, San Jose, CA) mass spec-
trometer. Spray voltage was set to 2.2 kV, RF lens level was set at
30%, and ion transfer tube temperature was set to 275°C. The Orbi-
trap Fusion Lumos was operated in positive ion data-dependent
mode with HCD fragmentation and orbitrap detector for all precur-
sor fragments for reporter ion quantitation. The mass spectrometer
was operated in data-dependent Top speed mode with 3 s per cycle.
The full scan was performed in the range of 350–1,500 m/z at nomi-
nal resolution of 120,000 at 200 m/z and AGC set to 4 × 105 with
maximal injection time of 50 ms. The MS2 scan was set with an
isolation width of 1.2 m/z with no offset, followed by selection of
precursors above an intensity threshold of 5 × 104 for higher-energy
collisional dissociation (HCD)–MS2 fragmentation with 38%
normalized collision energy. Dynamic exclusion was set to 60 s.
Monoisotopic precursor selection was set to peptide, and maximum
injection time was set to 120 ms. Charge states between 2 and 7
were included for MS2 fragmentation and analysis of fragment ions
in the orbitrap using 50,000 resolving power with auto normal range
scan starting from m/z 100 and AGC target of 5 × 104.
Global phosphoproteomic data analysis
Mass spectrometric raw data were searched against the UniProt
database (homo sapiens, including protein isoform sequences,
42,326 entries, downloaded 05/04/2018 from www.uniprot.org)
using MaxQuant (version 1.6.3.4) (Tyanova, Temu et al, 2016).
Variable modifications were set to: oxidation of methionine, phos-
phorylation of serine, theonine and tyrosine, deamidation of aspara-
gine, carbamylation of the peptide N-terminus and acetylation of the
protein N-terminus. Fixed modification was set as carbamidomethy-
lation of cysteine. False discovery rate threshold for peptide identifi-
cation was set to 5%. Quantitative result data were analysed using
an in-house R (Version 4.0.1) (R-Core-Team, 2020) analysis pipeline
(Script Files S1–S4). In brief, the intensities of peptides with more
than one observation within a single sample fraction were averaged.
Peptides quantified in several fractions were averaged in each
respective fraction independently to avoid reporter ion quan-
tification bias caused by differences in precursor co-isolation popu-
lations between different sample fractions. Data were normalized
and calibrated using variance stabilizing normalization (VSN)
(Huber et al, 2002, 2003). Statistical testing was carried out using
linear models for microarrays (limma) (Ritchie et al, 2015). under
application of robust hyperparameter estimation (Phipson et al,
2016).
To define putative CDKL5 substrates, mass spectrometric data
(Table EV1) were subjected to the volcano plot analysis shown in
Fig 4B, which revealed 37 phosphopeptides (31 unique sequences)
that were higher in abundance in the CDKL5 WT samples compared
with the KD samples; this group clustered away from the bulk of
phosphopeptides, and all the phosphopeptides within this cluster
had P < 0.0005. 22 of these 37 phosphopeptides had a single,
unique phosphorylation site (≥ 75% PTM score probability) and
were assigned as peptides of interest (Fig 4C). Additionally, phos-
phorylation sites were flagged if they had a PTM score probability of
≥ 0.994, corresponding to a false localization rate (FLR) of 1% (Fer-
ries et al, 2017). Peptide metadata were extracted from the follow-
ing databases: UniProt (gene ontology (GO) data, downloaded from
www.uniprot.org on 05/04/2020) (UniProt, 2019) and STRING (ver-
sion 11.0, downloaded from https://string–db.org/) (Szklarczyk
et al, 2019). GO terms and protein–protein interaction networks
were analysed using R (Script File S3) under application of Fisher’s
exact test against a background of all unique leading razor proteins
within this study (5,985 proteins as assigned by MaxQuant from the
identified peptides; isoforms of the same protein were not counted
as distinct proteins). GO terms were deemed significant if they had a
P-value of ≤ 0.01 and at least three proteins from the group of 25
unique proteins with significant peptides exhibiting the respective
GO term (foreground; 24 proteins with more and one protein with a
fewer phosphopeptides in CDKL5 WT samples compared with KD).
The protein–protein interaction network of the 24 unique proteins
containing a phosphopeptide higher in abundance in CDKL5 WT
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samples compared with KD was analysed by R (Script File S4) using
the STRING database with an interaction score threshold of 150.
Following R packages were used: ggplot2 (Wickham, 2016),
reshape2 (Wickham, 2007), vsn (Huber et al, 2002), limma (Ritchie
et al, 2015), seqinR (Charif & Lobry, 2007), plyr (Wickham, 2011),
stringr (Wickham, 2019), ggrepel (Slowikowski, 2020), ggpointden-
sity (Kremer, 2019), wesanderson (Ram & Wickham, 2018), extra-
font (Winston, 2014), scales (Wickham & Seidel, 2020), matrixStats
(Bengtsson, 2020), GO.db (Carlson, 2020), STRINGdb (Szklarczyk
et al, 2019), igraph (Csardi & Nepusz, 2006), gtools (Warnes et al,
2021, https://CRAN.R-project.org/package=gtools) and ggnetwork
(Briatte, 2020). Session information is listed in Text File S1. The
mass spectrometric nuclear phosphoproteomic data have been
deposited to the ProteomeXchange Consortium via the PRIDE
(Perez-Riverol et al, 2019) partner repository with the dataset identi-
fier PXD022916.
Data analysis Script Files (S1–S4), Session information text file
S1, and the relevant database links can be downloaded from the
Zenodo link: https://doi.org/10.5281/zenodo.5095151.
Extracted ion chromatogram (XIC) analysis
HEK293 cells were transfected using the calcium phosphate trans-
fection protocol as previously described (Munoz et al, 2018). Cells
were seeded at a confluence of 20–30% in 15-cm plates and 24 h
later were co-transfected with 5 μg DNA for each plasmid. Cells
were kept with the transfection mixture for 24 h and then either
mock-treated or incubated with H2O2 at a final concentration of
500 μM for 15 min. Plates were then washed twice with phosphate
saline buffer and lysed in a 50 mM Tris–HCl (pH 7.4)-based buffer
containing 0.27 M sucrose, 150 mM NaCl, 1% (v/v) Triton X-100,
0.5% (v/v) Nonidet NP-40 and 0.1% (v/v) 2-mercaptoethanol.
Lysis buffer was freshly supplemented with a protease inhibitor
cocktail (cOmpleteTM, EDTA-free Protease Inhibitor Cocktail),
benzonase at 50 U/ml, microcystin-LR at 10 ng/ml final concentra-
tion, phosphatase inhibitor cocktail-2 (Merck) at 1% (v/v),
olaparib (10 μM) and PDD00017273 (2 μM). Lysates were incu-
bated for 30 min at 4°C and clarified by centrifugation at 20,000 g
at 4°C.
For extracted ion chromatography (XIC) analysis, approximately
25 μl (settled volume) of FLAG-M2 agarose (Sigma-Aldrich; F1804)
beads was mixed with the following amounts of lysate for 2–3 h at
4°C: 10 mg of crude lysate for EP400 samples, 6 mg for Elongin A
and 2.5 mg for TTDN1. Precipitates were then extensively washed
with lysis buffer and finally once in cold PBS. Samples were then
denatured in 25 μl LDS–PAGE sample buffer (Thermo Fisher)
supplemented with 5% (v/v) 2-mercaptoethanol and then incubated
at 95°C for 5 min. All the immunoprecipitations were done in tripli-
cates using lysates from independent replicate transfections.
Samples were resolved in 4–12% Bis–Tris SDS–PAGE gradient gels
(NuPAGE, Thermo Fisher), and relevant bands were excised and
further processed for mass spectrometry as detailed below. Protein
bands excised from the gel were destained, and proteins were
digested with trypsin/LysC as described in Munoz et al (2018).
Peptides were labelled with TMT10plex (Thermo Fisher) according
to the manufacturer’s protocol, omitting the TMT131 label. Deviat-
ing from the protocol described in Munoz et al (2018), labelling
reaction was stopped using a 5% (w/v) hydroxylamine (Sigma)
solution. After labelling, the peptides were freeze-dried and stored
at 80°C until required.
Peptides were resuspended in 2% (v/v) acetonitrile (Merck) and
0.1% (v/v) formic acid (Merck), incubated for 15 min in an ultra-
sonic bath (VWR) and afterwards transferred into glass autosampler
vials (Waters). Peptides were separated and analysed using the
instrumental setup as described for the phosphoproteomic dataset.
Elution of peptides was achieved by a segmented linear gradient
over 120 min: initial 3 min of isocratic 3% B, followed by 3% B to
7% B in 2 min, to 25% B in 60 min, to 45% B in 30 min, to 95% B
in 5 min and isocratic state at 95% B for 5 min. This was followed
by a linear gradient from 95% B to 5% B within 0.5 min and
column re-equilibration for 14.5 min at 5% B. Flow rate was set to
300 nl/min. MS precursor ion scan was conducted within the Orbi-
trap at a resolution of 120,000 at 200 m/z. The top 15 precursors
within a mass range of 350–1,500 m/z were isolated in the quadru-
pole (0.7 Da isolation window, AGC target: 4 × 105, max. injection
time 50 ms) for subsequent fragmentation using HCD (38% normal-
ized collision energy, AGC target: 5 × 104, max. injection time
120 ms) and analysed in the Orbitrap with a resolution of 50,000 at
200 m/z. Analysed peptides were dynamically excluded after their
first measurement from reanalysis for a duration of 60 s. Data were
recorded in profile mode. In case of the file “Ivan_EP400–
TMT.raw”, an inclusion list of 628.3314 m/z (TMT-labelled phos-
phopeptide SSPVNRPSpSATNK) was set. Orbitrap-run metadata
were extracted using the MARMoSET R package as described on
their GitHub page (https://github.molgen.mpg.de/loosolab/MARMoSET,
accessed 28/11/2020) (Kiweler et al, 2019).
Mass spectrometric raw data were searched using MaxQuant
(version 1.6.3.4). Variable and fixed modifications with the exclu-
sion of carbamylation of the peptide N-terminus, FASTA and FDR
thresholds were set as described above for the phosphoproteomic
dataset. Data were analysed using in-house written R-scripts (see
Data availability), which were modified from Munoz et al (2018). In
brief, all TMT reporter intensities of the identified peptides of the
respective protein were normalized using VSN and intensities were
statistically tested using a t-test with subsequent Bonferroni correc-
tion of the significance threshold of a = 0.05. In cases where phos-
phopeptides were detected multiple times, the median intensity
within each respective TMT channel was taken for statistical testing.
Peptides with a P-value < 0.0125 (4 tests: EP400, TTDN1) or
< 0.00833 (6 tests: ELOA) were considered significant. Session infor-
mation is listed in Text File S2. The mass spectrometry-extracted ion
chromatography data have been deposited to the ProteomeXchange
Consortium via the PRIDE (Perez-Riverol et al, 2019) partner reposi-
tory with the dataset identifier PXD022975. Data analysis Script Files
S5–S8 and Session information text file S2, with links to the relevant
databases can be downloaded from the Zenodo link: https://doi.
org/10.5281/zenodo.4311494.
U–2–OS FokI transcription reporter assay
Recruitment of CDKL5 to FokI-induced DSBs
U-2-OS 265 transcription reporter cells (Tang, Cho et al, 2013) were
infected with retroviruses as explained above, to stably express GFP
alone or GFP-CDKL5 with an exogenous nuclear localization signal.
The cells were seeded onto an 8-well chamber slides 24 h before the
experiment. On the day of the experiment, cells were mock-treated
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or treated with 1 μ/ml doxycycline hyclate (D9891-G; Sigma-
Aldrich) for 3 h, to induce reporter gene transcription. To prolong
the retention of CDKL5 at FokI-induced DSBs, inhibitors of PARG
(0.3 μM) and ATM (10 μM) were added in the same media for 30–
45 min before adding 1 μM Shield-1 ligand (632189; Clontech Labo-
ratories UK Ltd) and 1 μM 4-hydroxytamoxifen (4-OHT; H7904–
5MG, Sigma) to induce mCherry-FokI expression and subsequent
DSB induction. Just 15 min after DSB induction, cells were live-
imaged on a Leica TCS SP8 MP microscope using water immersion
objective (HAP CL APO CS2 63×/1.40 water) supplemented with
5% CO2 maintained at 37°C. The fields of cells were quickly
scanned manually to image the cells showing co-localization of
mCherry-FokI foci with GFP signal. Imaging was done for 10 min,
making total time lapse of not more than 25 min post-DSB induc-
tion. Due to the CDKL5 transience at DSBs, the experiment was
done in multiple technical replicates on the same day by employing
staggered drug treatments, to ensure image collection of several
fields, and in three independent biological replicates.
MS2 foci
U-2-OS 263 IFII transcription reporter cells (Tang et al, 2013) trans-
fected with relevant siRNA were seeded onto eight-well chamber
slides and treated with 1 μM Sheild1 (632189, Clontech Laboratories
UK Ltd) and 1 μM 4–hydroxytamoxifen (4–OHT; H7904–5MG,
Sigma) for 3 h to induce mCherry–FokI expression and 1 mg/ml
doxycycline hyclate (D9891–G; Sigma-Aldrich) for an additional 3 h
to induce reporter gene transcription. Cells were fixed with 4%
paraformaldehyde in PBS (sc–281692; Santa Cruz), washed three
times with PBS, permeabilized with 0.2% (v/v) Triton X-100/PBS
for 3 min at RT, washed and stained with DAPI (1 μg/ml in PBS,
5 min, RT) and mounted using ProLong Gold antifade mounting
agent (P36934; Thermo). Imaging of fixed samples was carried out
on a Leica TCS SP8 MP microscope using oil immersion objective
(HAP CL APO CS2 63×/1.40 Oil). The number of transcription-
positive cells was scored manually from a total of 150–200 cells per
variable in each independent repeat. Data were plotted and analysed
by GraphPad Prism v9.0.0 using two-way ANOVA followed by the
Bonferroni multiple comparison test.
RNA isolation, reverse transcription and quantitative
real-time PCR
RNA was extracted from 1.2 × 106 cells using E.Z.N.A. Total RNA
Kit I (R6831–01) following the manufacturer’s protocol. cDNA was
synthesized from 1 μg RNA using iScript cDNA Synthesis Kit (170–
8891). qPCR was performed using a CFX384 real-time PCR system
(Bio-Rad), relevant primers with 2% (around 20 ng) of the cDNA
and TB GreenTM Premix Ex TaqTM II (Tli RNase H Plus; RR820L;
Takara) with two repeats for each PCR. The DDCt method was used
for evaluation. GAPDH gene was used as a housekeeping gene for
normalization. Data were analysed in Excel software (Microsoft)
and plotted in GraphPad Prism v9.0.0 software. Statistical signifi-
cance was determined by two-way ANOVA followed by Dunnett’s
multiple comparison test. Primers used are listed in Table EV2.
Gene silencing in response to I-PpoI-mediated DSB induction
2 × 105 cells/ml/well U-2-OS-pEP15 cells (DOX-inducible ER-I-PpoI
expressing stable cell line) were seeded into six-well plates for
siRNA transfection. Cells were transfected with 40 nM siControl or
siCDKL5-b (Dharmacon) using Interferin transfection reagent (Poly-
plus). Next day, 24 h after siRNA silencing, cells were transfected
with 3 μg pcDNA5D empty, pCDNA5D-CDKL5 WT or pCDNA5D-
CDKL5-K42R KD plasmids using jet-PEI transfection reagent (Poly-
plus). 16 h prior to the first 4-OHT treatment, 1 μg/ml doxycycline
hyclate (Sigma-Aldrich) was applied to induce the expression of I-
PpoI endonuclease. The following day, 1 μM 4-OHT (Sigma-
Aldrich) treatment was used at different time points (2, 4 and 8 h)
to facilitate the nuclear translocation of I-PpoI. 48 h after siRNA
transfection, cells were collected and destined for RNA and gDNA
isolation. For RNA isolation, ReliaPrep RNA Tissue Miniprep System
(Promega), but for gDNA isolation, ReliaPrep gDNA Tissue Mini-
prep System (Promega), is used according to the manufacturer’s
instructions. cDNA reverse transcription was performed with
Applied Biosystems TaqMan Reverse Transcription Reagents
(Thermo Fisher Scientific) according to the manufacturer’s instruc-
tions. qPCR experiments were performed on RotorGene Q qPCR
machine. For data evaluation, DDCt method was used. Data were
plotted and analysed by GraphPad Prism v9.0.0 using two-way
ANOVA followed by Tukey’s multiple comparison tests.
Data availability
The global phosphoproteomic mass spectrometric data have been
deposited in ProteomeXchange with the primary accession code
PXD022916 that can be downloaded from https://www.ebi.ac.uk/
pride/archive/projects/PXD022916. Data analysis Script Files (S1–
S4), Session information text file S1, and the relevant database links
can be downloaded from the Zenodo link: https://doi.org/10.5281/
zenodo.5095151. The extracted ion chromatogram data have been
deposited in ProteomeXchange with the primary accession code
PXD022975 (http://www.ebi.ac.uk/pride/archive/projects/PXD022975).
Data analysis Script Files (S5–S8) and Session information text
file S2, with links to the relevant databases, can be downloaded
from the Zenodo link: https://doi.org/10.5281/zenodo.4311494.
The microscopy source data links in the relevant figure legends are
kindly enabled by the Open Microscopy Environment (OMERO;
https://www.openmicroscopy.org/) (Allan, Burel et al, 2012).
Expanded View for this article is available online.
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